PharVision Advisers’s Domo DOMO Stock Holding History

PharVision Advisers’s Portfolio DOMO Stock Details DOMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,127	Closed	-$366K	–	762
2025 Q3	$366K	Buy	23,127 +12,160	+111%	+$188K	0.21%	115
2025 Q2	$153K	Buy	+10,967	New	+$110K	0.22%	230

Other funds holding DOMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RFM

RPD Fund Management New York $306M AUM 36.7% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Veradace Capital Management Dallas, Texas $112M AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PharVision Advisers's DOMO Position: Q4 2025 in Review

PharVision Advisers sold out of Domo (DOMO) in Q4 2025, closing a stake of 23,127 shares — an estimated $366K sold.

PharVision Advisers first reported a position in DOMO in Q2 2025 and held it in 2 quarters. The position peaked at $366K in Q3 2025. 130 funds tracked by Wall St. Rank hold DOMO as of Q4 2025.

PharVision Advisers reported no remaining Domo position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 23,127 Domo shares in Q4 2025, an estimated $366K.
PharVision Advisers first reported a position in Domo in Q2 2025 and held it in 2 quarters.
PharVision Advisers's Domo position peaked at $366K in Q3 2025.
130 funds tracked by Wall St. Rank held Domo as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.